Purpose: To create an accurate 6 MV Monte Carlo simulation phase space for the Varian TrueBeam treatment head geometry imported from CAD (computer aided design) without adjusting the input electron phase space parameters. Methods: GEANT4 v4.9.2.p01 was employed to simulate the 6 MV beam treatment head geometry of the Varian TrueBeam linac. The electron tracks in the linear accelerator were simulated with Parmela, and the obtained electron phase space was used as an input to the Monte Carlo beam transport and dose calculations. The geometry components are tessellated solids included in GEANT4 as GDML (generalized dynamic markup language) files obtained via STEP (standard for the exchange of product) export from Pro=Engineering, followed by STEP import in Fastrad, a STEP-GDML converter. The linac has a compact treatment head and the small space between the shielding collimator and the divergent arc of the upper jaws forbids the implementation of a plane for storing the phase space. Instead, an IAEA (International Atomic Energy Agency) compliant phase space writer was implemented on a cylindrical surface. The simulation was run in parallel on a 1200 node Linux cluster. The 6 MV dose calculations were performed for field sizes varying from 4 Â 4 to 40 Â 40 cm 2 . The voxel size for the 60 Â 60 Â 40 cm 3 water phantom was 4 Â 4 Â 4 mm 3 . For the 10 Â 10 cm 2 field, surface buildup calculations were performed using 4 Â 4 Â 2 mm 3 voxels within 20 mm of the surface. Results: For the depth dose curves, 98% of the calculated data points agree within 2% with the experimental measurements for depths between 2 and 40 cm. For depths between 5 and 30 cm, agreement within 1% is obtained for 99% (4 Â 4), 95% (10 Â 10), 94% (20 Â 20 and 30 Â 30), and 89% (40 Â 40) of the data points, respectively. In the buildup region, the agreement is within 2%, except at 1 mm depth where the deviation is 5% for the 10 Â 10 cm 2 open field. For the lateral dose profiles, within the field size for fields up to 30 Â 30 cm 2 , the agreement is within 2% for depths up to 10 cm. At 20 cm depth, the in-field maximum dose difference for the 30 Â 30 cm 2 open field is within 4%, while the smaller field sizes agree within 2%. Outside the field size, agreement within 1% of the maximum dose difference is obtained for all fields. The calculated output factors varied from 0:93860:015 for the 4 Â 4 cm 2 field to 1:08860:024 for the 40 Â 40 cm 2 field. Their agreement with the experimental output factors is within 1%. Conclusions: The authors have validated a GEANT4 simulated IAEA-compliant phase space of the TrueBeam linac for the 6 MV beam obtained using a high accuracy geometry implementation from CAD. These files are publicly available and can be used for further research.
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The goal of the present project was to develop a Monte Carlo application for the complex treatment head geometry imported from CAD for the Varian TrueBeam linac operated at 6 MV, and to quantify the agreement with experimental dose measurements without tuning the parameters of the input Parmela electron phase space. The output of our simulations is an International Atomic Energy Agency (IAEA)-compliant phase space file which is generic, not tuned for specific machine parameters, yet gives dose results in good agreement with experimental measurements. We also demonstrate the necessity to score the phase space on a cylindrical surface rather than conventional flat geometry due to the compact treatment head geometry.
II. METHODS AND MATERIALS

II.A. Linac simulation
The TrueBeam medical accelerator employs a biperiodic standing wave accelerator, incorporating an "energy switch" and a 270 bending magnet. The system is capable of achieving a sharp spectrum at energies ranging from 4 to 20 MeV for treatment and down to 2 MeV for imaging. 22 The linac consists of a linear array of microwave cavities in which RF fields, at frequencies corresponding to the cavity resonance frequencies, are maintained with the appropriate magnitude and phasing so as to accelerate a large fraction of the particles in their passage through the linac guide.
The simulation of the waveguide included the following four parts: (a) a simulation of an electron beam source for the guide to provide an input beam injected at a specified current and energy, (b) a means of generating the cavity RF fields, (c) a method for computing the trajectories of the various beam particles as they experience the accelerating Lorentz forces from their interaction with the various cavity and space charge fields, and (d) a provision for superimposing a focusing solenoidal magnetic field along the length of the guide (a) To model the input beam from the truebeam triode gun in Parmela, a macroparticle simulation was created based on measurements made using an electron beam analyzer. The device was used to examine the variation in the outer radius (envelope) of the beam generated in a field-free drift region as a function of the distance downstream from the gun. From this data, the Twiss parameters of the emittance ellipses 23 at the accelerator entrance could be inferred and the phase space distribution of the input beam determined. The injected beam is monoenergetic corresponding to the gun high voltage setting appropriate for the mode studied. The gun current was a nominal value measured with a toroidal current monitor. (b) The Superfish code, 24 a 2D RF finite difference cavity field solver, was used to generate the cavity field patterns. (c) Parmela, 16 a multiparticle, time-dependent beam dynamics simulation code was used to track the particles through the accelerator. The version used in this work was modified from an early 1980's version of the Los Alamos developed code and has been specialized for the linac development program at Varian. The input parameters to Parmela include the number and the types of cavities, cavity RF information, electron beam input specifications, solenoidal magnetic field parameters and various global parameters. The iterative procedure that was used to initially develop a design model for the guide consisted of a series of Parmela simulations, adjusting one or more of the guide parameters, particularly the cavity field levels and electron source parameters at each step until the specified output beam characteristics were achieved. The field profile employed matches the nominal design as verified on each guide via a beadpull measurement. 25 The solenoid field profile matches the profile obtained from Hall probe measurements. (d) The actual solenoid field level is adjustable in practice via the solenoid current. For this simulation work, it was left at the nominal setting, where fair agreement is obtained with spot size measurements taken with a stacked multichannel plate assembly (i.e., "spot camera").
On exit from the RF structure model, the beam is subjected to collimation on a 3 mm diameter, followed by a coordinate map to the target. 26 This map represents the action of the achromatic 270 stepped field bending magnet. Transport through the bending magnet also affects collimation at 63% in energy, representing the effect of the water cooled energy slit designed to provide a well-defined energy in all modes, including electron modes.
The beam output data after the bending magnet, resulting from the Parmela run with the design model as input, were in fair agreement with the measurements of beam energy (as inferred from experimental measurements of dose in a water tank), electron beam spot size and target current obtained with an actual accelerator system.
A plot of the Parmela phase space is shown in Fig. 1 . The beam energy measured in the central portion of the energy spectrum using calibration data for the bending magnet agreed within 4% with the calculated value, obtained from the cumulative acceleration of the particles by the longitudinal components of the cavity electric fields. The calculated spot size diameter was about 2 mm and an exact comparison with the spot camera measurements was performed. The Parmela coordinate and momenta distributions in this work are in agreement with previous studies. 5, 11, 12 However, the energy spectrum after the bending magnet indicates a nonGaussian distribution with a large narrow peak at 6.13 MeV and a smaller peak at 6.3 MeV. The presence of the two peaks is analogous to the bimodal structure obtained by Aubin et al., 21 although unlike their results, the high energy peak in the present work is much smaller in amplitude than the peak at the lower energy. As explained by Aubin, 21 the bimodal structure of the energy spectrum results from two stable (but separate) phase regions in the RF bucket for the captured electrons. This distribution is very different from the Gaussian model assumed in other studies. [11] [12] [13] [14] [15] 19 
II.B. Components implemented from CAD
The electronic engineering drawings of the treatment head were provided by Varian Medical Systems. The treatment head components exported from CAD (Ref. 6) were the target block holder, the two vacuum windows (at the exit from the bending magnet and at the entrance into the target holder), the protective window of the target, the target, the x-ray window, the primary collimator, the flattening filter friction ring, the relevant components of the ion chamber, 6 the backscatter filter, the shielding collimator, the upper and lower jaws, the base plate and the clipped corners. These clipped corners intersect only the 40 Â 40 cm 2 field and are connected to the base plate. Note that the flattening filter itself was modeled in GEANT4 using a polycone due to technical difficulties encountered during the standard for the exchange of product (STEP) to GDML conversion. 6 Part of the treatment head geometry is displayed in Fig. 1(a) . Notice that there is very little space between the shielding collimator and the divergent arc of the jaws. Only a cylindrical geometry of the phase space ensures no collisions between the stored phase space, the shielding collimator, and the upper jaws, even for the largest field. The geometrical complexity of the CAD imported treatment head components used in this study is apparent. Note that while TrueBeam can be operated in a flattening filter free (FFF) mode, in this work, the validation of the CAD import into GEANT4 is performed only for the conventional 6 MV flattened beam.
II.C. Computing facilities and numerical procedures
A load sharing facility (LSF) batch cluster has been used for the Monte Carlo simulation of the phase space and dose calculations. GEANT4 version v4.9.2.p01 was used. Thousand two hundred batches were launched independently on the LSF cluster. Our GEANT4 Monte Carlo application was divided in two parts. (1) We first simulated the transport of the particles starting with the Parmela phase space and ending with the shielding collimator. We developed a phase space writer, which stores the phase space information on a cylindrical surface as shown in Fig. 1(a) . (2) Then, starting with this patientindependent phase space file, the particles were transported through the rest of the treatment head components, and the dose deposited in the water phantom was recorded. For part (1), the Parmela input was recycled 80 times (i.e., a combined 6:9 Â 10 9 primary histories). For part (2), we imposed a recycling factor R between 4 and 20. The voxel size used for these calculations was 4 Â 4 Â 4 mm 3 in order to have a dose resolution similar to that corresponding to the experimental ion chamber measurements. In the dose buildup region, the voxel volume was 4 Â 4 Â 2 mm 3 . The CPU time for each of the batch jobs was 11.1 h for part 1 and 2.8 h for part 2. The obtained IAEA-compliant phase space files contain the particle index (0 for photon, 1 for electron, 2 for positron, and 3 for neutron), the x, y, and z coordinates, the direction cosines p x and p y , the sign of p z , and the particle energy. The GEANT4 physics list was based on the standard electromagnetic processes. We used the newest GEANT4 multiple scattering model, G4UrbanMscModel2, which gives the best results for electron scatter in external beam radiotherapy. 18 A value of 0.1 mm 18 was chosen for the particle range cutoff parameter, hence the energy threshold in water was 1.11 keV (for photons), 84.66 keV (for electrons), and 83.53 keV (for positrons).
II.D. Experimental data acquisition and uncertainties
All measurements were made in water with a compact chamber CC04 (IBA Dosimetry), except for the depth doses in the first 7 mm from the surface, where a photon diode (IBA Dosimetry) was used for the 4 Â 4 cm 2 field, and a parallel ion chamber (MSKCC design) was used for larger fields. Polarity effects, ion recombination effects, and X-Y jaw profile dependence were observed during the truebeam commissioning procedure for the CC04 ion chamber. No significant in-field variation is observed; however, the peripheral dose is influenced by all three of these effects. Using one polarity, the peripheral dose was over-measured by 0.3% of the CAX dose for the 30 Â 30 cm 2 field. As expected, this error decreased with field size. Due to ion recombination the doses in peripheral dose regions normalized to the CAX was over-measured by up to 0.3%. Peripheral doses normalized to the CAX are 1% greater under the Y-jaws in these data than under the X-jaws. Also, uncorrected polarity and recombination effects increased the measured depth dose up to 0.3% each at large depths. Finally, mechanical accuracy was determined to be less than 1 mm over 30 cm in all three scanning dimensions.
II.E. Conversion to dose and data comparison
We converted the simulations results to dose (cGy=MU) to allow a direct comparison with ionization chamber measurements. We divided the deposited dose to the total number of primary particles used in the simulation for a particular field size. 
III. RESULTS
Monte Carlo simulations were performed for different field sizes, including small (4 Â 4 cm 2 open fields are displayed. All calculations used a source to surface distance of 100 cm. For the dose profiles, both the in-plane and cross-plane directions were considered. No difference was observed between these two directions for the in-field dose profiles, while the out-of-field dose displayed small differences, no larger than 1%. The profile depths were 2.5, 5, 10, 20, and 30 cm.
The depth dose results are shown in Fig. 2 . The curves represent the experimental measurements, while the points correspond to the Monte Carlo calculations. Note that 98% of the calculated data points agree within 2% with the experimental measurements for depths between 2 and 40 cm. For depths between 5 and 30 cm, agreement within 1% with experiment is obtained for 99% (for 4 Â 4 cm 2 field), 95% (for 10 Â 10 cm 2 field), 94% (for 20 Â 20 and 30 Â 30 cm 2 fields), and 89% (for 40 Â 40 cm 2 field) of the Monte Carlo data points, respectively. For the surface buildup region, Monte Carlo calculations were performed using a 2 mm wide voxel up to 20 mm depth, and the results were compared against both the CC04 and the plane parallel ion chamber experimental data. The agreement in the buildup region is within 2% for the dose difference between the measurements using the ion chamber and Monte Carlo data sets. Only the point corresponding to the first voxel at 1 mm depth from the surface is characterized by a 5% deviation. Note, however, that the experimental accuracy in the surface buildup region is estimated to be within 5%.
The dose profiles are shown in Fig. 3 . at 2.5 cm depth. The continuous curves represent the experimental measurements. For the dose profiles at 2.5 and 10 cm depths, the maximum dose difference is within 2% for the in-field regions, and within 1% for the out-of-field values for field sizes up to 30 Â 30 cm 2 . The 30 Â 30 cm 2 open field shows dose differences in the horn region up to 3%. At even larger depth (i.e., 20 cm), the in-field maximum dose difference for the 30 Â 30 cm 2 open field is within 4%, while the smaller field sizes preserve the same level of agreement (i.e., within 2%). At both small and large depths, a few exceptions appear for the interpolated points corresponding to the field edges and penumbra regions, where the interpolation was performed using a simple linear function. For the 40 Â 40 cm 2 field, the maximum dose difference between the experiment and Monte Carlo deviates from the 2% accuracy goal, especially in the horn region, for the dose measurements corresponding to the smaller depths (2.5 and 5.0 cm). The largest deviations are equal to 5.5%. This could be due to the statistical imprecision associated with the x and y coordinates of the Parmela simulated electron phase space, which can be as large as 10%. As explained in Sec. IV, these errors can significantly affect the radial spread of the electron beam and have a direct impact on the magnitude of the horns. 5, [11] [12] [13] Overall, the off-axis ratio calculated with GEANT4 at large fields are low by 3% for the 30 Â 30 cm 2 open field and by 5% for the largest field of 40 Â 40 cm 2 , with an uncertainty of < 1:5%. This is consistent with the results by Faddegon et al.
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The experimental output factors measured at the maximum dose depth d max ¼ 1:4 cm, together with the Monte Carlo output factors OF c , and their standard errors are shown in Table I for field sizes varying from 4 Â 4 to 40 Â 40 cm 2 . The agreement between the experimental and calculated values is well within 1%.
The statistical uncertainty of our dose calculations was estimated using the recommendations from TG-105. 2 For reporting the statistical uncertainty over a certain volume, the voxels receiving a dose larger than 50% of the maximum dose D max were considered, and the fractional uncertainty in the average dose for these particular voxels, F D>0:5D max , was calculated. The values we obtained for Since the same input phase space file was reused a large number of times, which could in principle introduce latent variance effects, 28, 29 we have calculated the average dose variance for the 10 Â 10 cm 2 open field and looked at its dependence on R. The variance was calculated by summing the contributions of all the voxels in 5 Â 5 cm 2 central region of the phantom. We have verified that as R increases, the variance of the average dose decreases. A saturation at large R would be an indication of latent variance effects, not observed in our study. Instead, a linear dependence of the average dose variance on the inverse of the recycling factor is obtained, indicating that the current calculations do not suffer from latent variance effects.
IV. DISCUSSIONS AND CONCLUSIONS
In this study, we validated the 6 MV beam Monte Carlo dose simulations using high precision geometry implementation from CAD and input electron beam parameters fixed by the Parmela phase space. The adjustable Parmela parameters were fixed based on their experimental correspondents set in practice by the operation of the linac. We have generated phase space files, scoring to a cylindrical geometry such that we can record particle characteristics upstream of the movable jaws. The phase space files are available on the IAEA phase space database.
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The agreement with experiment, mostly within 2%, is within the dose accuracy goals set by the Report of Task Group 65 (Ref. 31): "the accuracy of computed dose distributions should be between 1 and 2%." The calculated and experimental output factors agree well within 1%.
While previous Monte Carlo studies have obtained agreement within 1%, 11, 12, 21, 32 it is important to note the differences in the input phase space and the geometry implementation used, as well as, in the data analysis involving dose normalization using field dependent quantities 12, 21, 32 (instead of a unique field independent scaling 11 ), multiple iterations to determine the optimal electron spectrum, as well as smoothing techniques. 21 There are four possible factors affecting the level of agreement obtained in this study: the approximations used in the Parmela simulations, the uncertainties in component positioning and material composition, the physics used in GEANT4, and the uncertainties in experimental data acquisition.
The uncertainty in Parmela simulations are estimated to be within 4% for the energy distribution and up to 10% for the transverse coordinates. Let us assume that the peak of the Parmela energy spectrum shifts by 4%. As shown by Tzedakis, 12 a 4% decrease in the mean energy value of the Gaussian energy distribution from 6.4 to 6.1 MeV leads to higher "horns" and produces a dose difference as large as 2%. The impact of the more predominant error in the transverse coordinates can be estimated as well. Since the FWHM of the spatial coordinate distributions is 1.4 mm for both x and y, a 10% residual error means that FWHM can fluctuate by 60.14 mm. A decrease in the FWHM value of the spatial coordinate distribution from 1.1 to 0.9 mm leads to higher horns 12 and a dose difference as large as 1%. Either one of these scenarios may bring our simulations into closer agreement with experiment.
The possible residual errors in GEANT4 are due to the physics list and=or the choice for the range cutoff. A range cutoff reduction from 1 to 0.01 mm produces less than a 2% effect on the calculated relative dose distributions in the high dose region, as shown by Faddegon et al. 18 This effect is not negligible and it would be useful to have more detailed studies to decide the optimal range cut for a particular energy. However, this study was performed for a different physics list with an older version of GEANT4, and we stress the need for additional studies for the current version of the toolkit.
Moreover, the component positioning can significantly change the dose distributions 4 and in addition, material compositions from manufacturers are not known exactly. For example, the primary collimator, the jaws and the multileaf collimator are made of a tungsten alloy, which contains 95% W and the remaining 5% containing a metallic binder made of Ni, Fe and Cu. For our simulations, the following combination was selected: 2.8% Ni, 1.2% Fe and 1% Cu, which was one of the three options provided by the manufacturer. It is important to point out that the ratios of these elements can vary and will slightly affect the radiation transport properties. It would be useful to know the impact of this type of material composition uncertainty on the output data.
Future work will address the simulation of 6 MV FFF and higher energy photon beams, the implementation of variance reduction techniques, along with a framework to run the simulation on a cloud computing cluster.
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